Main menu


You are here

Home

Treatments

In China, vaccine hesitancy lingers even as COVID cases surge

Tue, 2023-01-03 13:40 — mike kraft
'I don't trust it:' Vaccine hesitancy lingers even as China COVID cases surge The problem is a growing headache for Beijing as it tries to persuade more people to get vaccinated in the face of a spike in infections and the prospect of more than 1.5 million deaths after the lifting of strict anti-COVID measures. David Kirton Reuters

...

Country / Region Tags: 
Asia
China
General Topic Tags: 
COVID-19
Boosters
Treatments
Contagion
Data
Disease
Disease Prevention
Government
Health
Mutations
Pandemics
Public Attitudes
Public Health
Science
Social behavior
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report

COVID booster prompts good immune response, except after recent infection --study

Tue, 2023-01-03 12:50 — mike kraft
COVID booster prompts good immune response, except after recent infection CIDRAP

A study today in Clinical Infectious Diseases finds that a third COVID-19 vaccine dose triggered a robust immune response, regardless of whether recipients had been infected more than 3 months earlier, but it didn't significantly increase antibody levels in those infected less than 3 months before.

...

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Boosters
Treatments
Data
Disease
Disease Prevention
Health
Medical Testing
Mutations
Pandemics
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Analysis

China, EU in dispute over China's COVID crisis, Beijing threatens countermeasures

Tue, 2023-01-03 10:07 — mike kraft
EU, Beijing heading for collision over China's COVID crisis BRUSSELS (AP) — The European Union and China on Tuesday moved closer to a political standoff over the COVID-19 crisis, with Beijing vehemently rejecting travel restrictions some EU nations have started to impose that could well be expanded in coming days. AP NEWS
Country / Region Tags: 
Asia
China
Europe
Global
United States
General Topic Tags: 
COVID-19
Treatments
Contagion
Disease
Disease Prevention
Government
Health
Mutations
Pandemics
Policy
Politics
Public Health
Problem, Solution, SitRep, or ?: 
Situation Report

It's Getting Tougher to Afford Health Care, Even With Employer-Sponsored Insurance

Thu, 2022-12-29 22:19 — FNUOvviyaa
It's Getting Tougher to Afford Health Care, Even With Employer-Sponsored Insurance US News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news you can use in politics, business, health, and education. HealthDay US News & World Report

...

Researchers found that over the past 20 years, a growing number of Americans with job-based health insurance have been skipping medical care due to costs. Women have been particularly hard-hit.

...
Country / Region Tags: 
United States
General Topic Tags: 
Treatments
Hospitals
Public Health
Research
Problem, Solution, SitRep, or ?: 
Problem

A promising new Covid pill shows key advantages over Paxlovid in trial

Thu, 2022-12-29 22:10 — FNUOvviyaa
A promising new Covid pill shows key advantages over Paxlovid in trial A Chinese antiviral pill was found to be as effective as Paxlovid in a Phase 3 trial, and it appeared to cause fewer side effects. NBC News

...

"You have a medication that looks to be just as good as Paxlovid, but less cumbersome," said Dr. Panagis Galiatsatos, an assistant professor of medicine at Johns Hopkins Medicine in Baltimore.

...

Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Symptoms
Treatments
Research
Problem, Solution, SitRep, or ?: 
Situation Report

COVID Smell Loss: 'Retraining' Mostly Flops in Trial

Thu, 2022-12-29 21:48 — FNUOvviyaa
COVID Smell Loss: 'Retraining' Mostly Flops in Trial Some patients did recover olfactory function with two-prong therapy, however Kate Kneisel medpagetoday

...

Bimodal olfactory training with visual cues and the use of patient-preferred scents did not produce a clinically meaningful improvement in sense of smell among individuals with COVID-19–related olfactory loss, a 275-patient randomized trial showed.

...

Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Symptoms
Treatments
Research
Problem, Solution, SitRep, or ?: 
Analysis

Epidemics That Weren't: How Countries Shut Down Recent Outbreaks

Tue, 2022-12-27 20:44 — FNUOvviyaa
Epidemics That Weren't: How Countries Shut Down Recent Outbreaks When Ebola swept through eastern Congo in 2018, it was a struggle to track cases. Dr. Billy Yumaine, a public health official, recalls steady flows of people moving back and forth across the border with Uganda while others hid sick family members in their homes because they feared the authorities. It took at least a week to get test results, and health officials had difficulty isolating sick people while they waited. It took two years for the country to bring that outbreak under control, and mor YahooNews
Country / Region Tags: 
United States
General Topic Tags: 
Ebola
Treatments
Disease Prevention
Government
Problem, Solution, SitRep, or ?: 
Analysis

Long COVID: What scientists have learned about the symptoms affecting millions around the world

Mon, 2022-12-26 17:19 — FNUOvviyaa
Long COVID: What scientists have learned about the symptoms affecting millions around the world A British historian, an Italian archaeologist and an American preschool teacher each helped bring long COVID into the public's consciousness. CBS News

...

Country / Region Tags: 
United States
General Topic Tags: 
COVID-19
Symptoms
Treatments
Demographics
Research
Problem, Solution, SitRep, or ?: 
Analysis

China's COVID cases overwhelm hospitals

Mon, 2022-12-26 16:59 — FNUOvviyaa
China's COVID cases overwhelm hospitals In more than three decades of emergency medicine, Beijing-based doctor Howard Bernstein said, he has never seen anything like this. Martin Quin Pollard Reuters

...

Country / Region Tags: 
United States
General Topic Tags: 
Capacity
COVID-19
Treatments
Hospitals
Medical Personnel
Problem, Solution, SitRep, or ?: 
Problem

BioNTech starts human trial to test malaria vaccine

Fri, 2022-12-23 22:04 — FNUOvviyaa
BioNTech starts human trial to test malaria vaccine BioNTech on Friday initiated an early-stage study to evaluate its experimental malaria vaccine in humans, the German drugmaker said. Reuters Reuters

...

Country / Region Tags: 
United States
General Topic Tags: 
Treatments
Disease Prevention
Medical Testing
Research
Vaccinations
Problem, Solution, SitRep, or ?: 
Situation Report

Pages

Subscribe to Treatments
howdy folks
Page loaded in 0.412 seconds.